James R Neal Processa Pharmaceuticals, Inc. (PCSA) insider trading activity

PCSA Quotes by TradingView

James R Neal is of Processa Pharmaceuticals, Inc.. Currently has a direct ownership of 14,407 shares of PCSA, which is worth approximately $13,254. The most recent transaction as insider was on Jun 27, 2023, when has been sold 14,407 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 14.4K
0% 3M change
0% 12M change
Total Value Held $13,254

James R Neal Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 27 2023
BUY
Exercise of conversion of derivative security
-
14,407 Added 50.0%
14,407 Common Stock

Also insider at

XOMA
XOMA Corp Healthcare
CEO
PALI
PALISADE BIO, INC. Healthcare
Director
IGNYU
Ignyte Acquisition Corp. Financial Services
AKTX
Akari Therapeutics Plc Healthcare
JRN

James R Neal

Emeryville, CA

Track Institutional and Insider Activities on PCSA

Follow Processa Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells PCSA shares.

Notify only if

Insider Trading

Get notified when an Processa Pharmaceuticals, Inc. insider buys or sells PCSA shares.

Notify only if

News

Receive news related to Processa Pharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on PCSA